# ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.

> **NCT07737964** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Montpellier** · enrollment: 366 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT07737964
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2029-01
- **Final completion:** 2029-01
- **Target enrollment:** 366 (ESTIMATED)
- **Last updated:** 2026-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07737964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07737964, "ACetazolamide in Patients With Heart Failure, to Decrease Weight and relIEVE Symptoms.". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07737964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*